2010
DOI: 10.1016/j.niox.2009.12.001
|View full text |Cite
|
Sign up to set email alerts
|

LPS mediated injury to oligodendrocytes is mediated by the activation of nNOS: Relevance to human demyelinating disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

2
12
0

Year Published

2010
2010
2020
2020

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 20 publications
(14 citation statements)
references
References 54 publications
2
12
0
Order By: Relevance
“…nNOS and eNOS are constitutively expressed and require calcium and calmodulin for activation, whereas iNOS is largely calcium independent and induced in inflammatory conditions (Knowles and Moncada, 1994). Although nNOS and eNOS have been shown to be elevated in experimental autoimmune encephalomyelitis (EAE), one of the commonly used animal models of MS (Wu and Tsirka, 2009;Yao et al, 2010), iNOS induction in reactive microglia/macrophages and astrocytes is believed to be the predominant source of NO (Broholm et al, 2004;Sun et al, 2010). It is known that NO is neither a potent oxidant nor a strong reductant (Calabrese et al, 2009), but it can rapidly react with superoxide to produce the powerful oxidant peroxynitrite (Beckman et al, 1990;Pacher et al, 2007).…”
mentioning
confidence: 99%
“…nNOS and eNOS are constitutively expressed and require calcium and calmodulin for activation, whereas iNOS is largely calcium independent and induced in inflammatory conditions (Knowles and Moncada, 1994). Although nNOS and eNOS have been shown to be elevated in experimental autoimmune encephalomyelitis (EAE), one of the commonly used animal models of MS (Wu and Tsirka, 2009;Yao et al, 2010), iNOS induction in reactive microglia/macrophages and astrocytes is believed to be the predominant source of NO (Broholm et al, 2004;Sun et al, 2010). It is known that NO is neither a potent oxidant nor a strong reductant (Calabrese et al, 2009), but it can rapidly react with superoxide to produce the powerful oxidant peroxynitrite (Beckman et al, 1990;Pacher et al, 2007).…”
mentioning
confidence: 99%
“…Nitric oxide plays a major role in a number of aspects of MS through triggering inflammatory factors, inducing neuronal death, and causing demyelination (Brenner et al 2001;Encinas et al 2005;Yao et al 2010). Increased serum and CSF concentrations of NO metabolites have been noted in MS patients, and have been suggested to cause damage to myelin and oligodendrocytes via lipid peroxidation (Speciale et al 2000;Kouhsar et al 2011).…”
Section: Discussionmentioning
confidence: 99%
“…TLRs receptors, expressed mainly in sentinel cells of the immune system (50), also have important functions in oligodendrocytes (3,49). Yao et al through the in vitro and in vivo investigations on TLR mediated injury of demyelination by lipopolysaccharide, showed the involvement of increased NO production, and more importantly, a susceptibility of the oligodendrocytes to NO-mediated cell death by the activation of nNOS but not of iNOS (59,60).…”
Section: +mentioning
confidence: 99%
“…Different isoforms of nitric oxide synthase (NOS) produce NO. For instance, neuronal NOS (nNOS) is present exclusively in neurons and the inducible NOS (iNOS) can be activated in glial cells; iNOS and nNOS are present in oligodendrocytes (59,60). Other than the physiological actions, NO can cause cellular damage and act as a key mediator of neurodegeneration in many diseases, including Parkinson's disease, Alzheimer's disease, amyotrophic lateral sclerosis, Huntington's disease, and stroke (20).…”
mentioning
confidence: 99%
See 1 more Smart Citation